인쇄하기
취소
|
Medytox recorded the largest performance ever since its foundation on the first quarter of the year.
A biopharmaceutical company, Medytox(CEO Hyun-ho Jung), made an official notice of its tentative performance on the 2nd that it achieved KRW 28.8 billion sales and KRW 16.6 billion profits on the 1st quarter of 2016, increased by 53% and 49% respectively compared to the same quarter of the yea...